Mastocytosis, Systemic

Known as: Systemic tissue mast cell disease, MAST CELL DISEASE, SYSTEMIC, Systemic Mastocytosis 
A rare disease in which too many mast cells (a type of immune system cell) are found in the skin, bones, joints, lymph nodes, liver, spleen, and… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Systemic sclerosis, also called scleroderma, is an immune-mediated rheumatic disease that is characterised by fibrosis of the… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
To provide an update to the “Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock,” last… (More)
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND There have been conflicting reports on the efficacy of recombinant human activated protein C, or drotrecogin alfa… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Clinical phenotype in systemic mastocytosis (SM) is markedly variable, which complicates prognostication and decision making… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
TET2 (TET oncogene family member 2) is a candidate tumor suppressor gene located at chromosome 4q24, and was recently reported to… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Increased concentrations of DNA-containing immune complexes in the serum are associated with systemic autoimmune diseases such as… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2004
Review
2004
Systemic mastocytosis is a clonal disorder of the mast cell and its progenitor. The symptoms of systemic mastocytosis are due to… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Drotrecogin alfa (activated), or recombinant human activated protein C, has antithrombotic, antiinflammatory, and… (More)
  • figure 1
  • table 3
  • table 2
  • table 4
  • figure 2
Is this relevant?
Review
2001
Review
2001
The term 'mastocytosis' denotes a heterogeneous group of disorders characterized by abnormal growth and accumulation of mast… (More)
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Better methods are needed to assess mast-cell activation in vivo and to distinguish the activation of mast cells from that of… (More)
Is this relevant?